Sysmex Stock Price, News & Analysis (OTCMKTS:SSMXY)

$41.41 0.24 (0.58 %)
(As of 01/23/2018 10:59 AM ET)
Previous Close$41.54
Today's Range$40.95 - $41.54
52-Week Range$27.18 - $42.19
Volume1,103 shs
Average Volume22,753 shs
Market Capitalization$17.04 billion
P/E Ratio47.06
Dividend Yield0.25%

About Sysmex (OTCMKTS:SSMXY)

Sysmex Corporation, together with its subsidiaries, engages in the research and development, production, sale, export and import, and service of in-vitro diagnostic instruments, reagents, and related software for the use in hematology, urinalysis, immunochemistry, clinical chemistry, and hemostasis worldwide. It offers three-part and five-part white blood cell differentiation instruments for use in hematology; systems for high-volume testing in labs; and hematology analyzers for animals. The company also provides urine formed sediment analysis systems; automated immunochemistry analyzers, which perform assays on minute sample quantities, as well as reagents for immunochemistry; and instruments for determining the activity of blood hemostasis, as well as support services for hemostasis products. In addition, it offers one-step nucleic acid amplification method for the use in systems for the detection of lymph node metastasis of breast and other types of cancer. Further, the company provides BEAMing technology that is used to detect minute quantities of genes in the blood for the early detection and recurrence monitoring of cancer, monitoring the effects of anti-cancer drugs, and the creation of new tests. Additionally, it offers automated clinical chemistry analyzers; and health monitoring systems that measure hemoglobin levels without blood sampling and are used for monitoring athletic condition, as well as provides services for producing proteins from silkworms using gene recombinant technology. The company serves national and other public hospitals, private hospitals, universities, research institutes, other medical institutions, etc. The company was formerly known as TOA Medical Electronics Co., Ltd. and changed its name to Sysmex Corporation in October 1998. Sysmex Corporation was founded in 1968 and is headquartered in Kobe, Japan.

Receive SSMXY News and Ratings via Email

Sign-up to receive the latest news and ratings for SSMXY and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry N/A


Debt-to-Equity RatioN/A
Current Ratio2.61%
Quick Ratio1.94%


Trailing P/E Ratio47.057352924465
Forward P/E Ratio46.01
P/E GrowthN/A

Sales & Book Value

Annual Sales$2.31 billion
Price / Sales7.48
Cash Flow$1.17 per share
Price / Cash35.29
Book Value$4.51 per share
Price / Book9.18


Trailing EPS$0.88
Net Income$362.81 million
Net Margins15.72%
Return on Equity19.52%
Return on Assets14.75%


Outstanding Shares417,420,000

Sysmex (OTCMKTS:SSMXY) Frequently Asked Questions

What is Sysmex's stock symbol?

Sysmex trades on the OTCMKTS under the ticker symbol "SSMXY."

When will Sysmex make its next earnings announcement?

Sysmex is scheduled to release their next quarterly earnings announcement on Friday, February, 2nd 2018. View Earnings Estimates for Sysmex.

Who are some of Sysmex's key competitors?

How do I buy Sysmex stock?

Shares of Sysmex can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Sysmex's stock price today?

One share of Sysmex stock can currently be purchased for approximately $41.41.

How big of a company is Sysmex?

Sysmex has a market capitalization of $17.04 billion and generates $2.31 billion in revenue each year. The company earns $362.81 million in net income (profit) each year or $0.88 on an earnings per share basis.

How can I contact Sysmex?

Sysmex's mailing address is 1-5-1 Wakinohama-Kaigandori Chuo-ku, Kobe M0, 651-0073. The company can be reached via phone at 817-8265-0500.

MarketBeat Community Rating for Sysmex (SSMXY)

Community Ranking:  2.2 out of 5 (star star)
Outperform Votes:  26 (Vote Outperform)
Underperform Votes:  32 (Vote Underperform)
Total Votes:  58
MarketBeat's community ratings are surveys of what our community members think about Sysmex and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

Sysmex (OTCMKTS:SSMXY) Analyst Ratings History

No equities research coverage for this company has been tracked by MarketBeat


Sysmex (OTCMKTS:SSMXY) Earnings History and Estimates Chart

Earnings by Quarter for Sysmex (OTCMKTS:SSMXY)

Sysmex (OTCMKTS SSMXY) Earnings History by Quarter

DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
8/4/2017Q1 2018$0.18ViewN/AView Earnings Details
5/10/2017Q4 2017$0.19ViewN/AView Earnings Details
2/3/2017Q3 2017$0.19ViewN/AView Earnings Details
11/9/2016Q2 2017$0.33ViewN/AView Earnings Details
8/5/2016Q1 2017$0.21ViewN/AView Earnings Details
5/11/2016Q4 2016$0.20ViewN/AView Earnings Details
2/3/2016Q3 2016$0.20ViewN/AView Earnings Details
11/5/2015Q2 2016$0.18ViewN/AView Earnings Details
8/5/2015Q1 2016$0.13ViewN/AView Earnings Details
(Earnings results data provided by Zacks Investment Research)


Sysmex (OTCMKTS:SSMXY) Earnings Estimates

Current Year EPS Consensus Estimate: $0.9 EPS
Next Year EPS Consensus Estimate: $0.96 EPS


Dividend History for Sysmex (OTCMKTS:SSMXY)

No dividend announcements for this company have been tracked by

Insider Trades

Insider Trading History for Sysmex (OTCMKTS SSMXY)

No insider trades for this company have been tracked by


Sysmex (OTCMKTS SSMXY) News Headlines


SEC Filings

Sysmex (OTCMKTS:SSMXY) SEC Filings

This page is loading this company's SEC Filings. Please wait...

Social Media


Financials are not available for this stock.


Sysmex (OTCMKTS SSMXY) Stock Chart for Tuesday, January, 23, 2018

Loading chart…

This page was last updated on 1/23/2018 by Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with's FREE daily email newsletter.